AAPL312.66+4.03 (+1.31%) ▲|ABBV254.76-6.31 (-2.42%) ▼|ABT95.63+0.23 (+0.24%) ▲|ACN136.96-0.39 (-0.28%) ▼|ADBE218.07-1.65 (-0.75%) ▼|AMAT592.79-10.25 (-1.70%) ▼|AMD552.05+34.23 (+6.61%) ▲|AMGN366.44-7.71 (-2.06%) ▼|AMT162.11-3.92 (-2.36%) ▼|AMZN244.16+1.49 (+0.61%) ▲|AVGO373.90+13.45 (+3.73%) ▲|AXP356.03+4.07 (+1.16%) ▲|BA234.54+8.05 (+3.55%) ▲|BAC59.90+1.17 (+1.99%) ▲|BKNG181.03-3.53 (-1.91%) ▼|BLK1,011.21+15.48 (+1.55%) ▲|BMY56.70-1.43 (-2.46%) ▼|BNY149.96+3.34 (+2.28%) ▲|BRK-B506.58-1.20 (-0.24%) ▼|C143.86+3.89 (+2.78%) ▲|CAT969.92+6.39 (+0.66%) ▲|CL93.39-1.74 (-1.83%) ▼|CMCSA23.38-0.41 (-1.72%) ▼|COF206.50+1.38 (+0.67%) ▲|COP103.58-1.15 (-1.10%) ▼|COST950.25-1.42 (-0.15%) ▼|CRM165.65-0.46 (-0.28%) ▼|CSCO113.98+1.29 (+1.14%) ▲|CVS102.08-2.64 (-2.52%) ▼|CVX168.10-1.10 (-0.65%) ▼|DE635.24+13.97 (+2.25%) ▲|DHR193.62-4.31 (-2.18%) ▼|DIS97.41-2.09 (-2.10%) ▼|DUK125.97-3.63 (-2.80%) ▼|EMR141.56+2.51 (+1.81%) ▲|FDX309.93-3.07 (-0.98%) ▼|GD376.88+3.34 (+0.89%) ▲|GE378.68+1.63 (+0.43%) ▲|GEV1,152.04+38.93 (+3.50%) ▲|GILD129.61-1.66 (-1.26%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG364.90+8.72 (+2.45%) ▲|GOOGL366.46+6.55 (+1.82%) ▲|GS1,055.29+34.29 (+3.36%) ▲|HD350.65-7.25 (-2.03%) ▼|HON231.18+1.32 (+0.57%) ▲|IBM299.52+10.00 (+3.45%) ▲|INTC122.20+1.85 (+1.54%) ▲|INTU272.14-3.21 (-1.17%) ▼|ISRG432.83+6.82 (+1.60%) ▲|JNJ259.33-3.71 (-1.41%) ▼|JPM337.72+4.75 (+1.43%) ▲|KO82.96-1.18 (-1.40%) ▼|LIN540.52-6.12 (-1.12%) ▼|LLY1,200.06-13.85 (-1.14%) ▼|LMT538.00-7.91 (-1.45%) ▼|LOW223.78-3.72 (-1.64%) ▼|LRCX350.20-1.21 (-0.34%) ▼|MA533.10-6.29 (-1.17%) ▼|MCD279.50-1.13 (-0.40%) ▼|MDLZ59.17-1.74 (-2.86%) ▼|MDT83.06-0.13 (-0.16%) ▼|META600.29+17.39 (+2.98%) ▲|MMM159.15-1.29 (-0.80%) ▼|MO71.88-0.83 (-1.14%) ▼|MRK126.78-2.78 (-2.15%) ▼|MS222.10+8.17 (+3.82%) ▲|MSFT386.74-3.75 (-0.96%) ▼|MU984.75+9.19 (+0.94%) ▲|NEE87.44-0.90 (-1.02%) ▼|NFLX76.02-1.63 (-2.10%) ▼|NKE43.34-0.75 (-1.70%) ▼|NOW107.93+1.61 (+1.51%) ▲|NVDA195.55+0.72 (+0.37%) ▲|ORCL143.76+3.49 (+2.49%) ▲|PEP143.29-0.93 (-0.64%) ▼|PFE23.72-0.60 (-2.47%) ▼|PG149.31-2.10 (-1.39%) ▼|PLTR132.54+3.24 (+2.51%) ▲|PM184.76+2.49 (+1.37%) ▲|QCOM186.48+10.23 (+5.80%) ▲|RTX201.37+2.12 (+1.06%) ▲|SBUX102.11-2.16 (-2.07%) ▼|SCHW100.62+3.62 (+3.73%) ▲|SO95.99-1.99 (-2.03%) ▼|SPG225.00-1.06 (-0.47%) ▼|T20.58+0.00 (+0.00%) ▲|TMO517.60-5.84 (-1.12%) ▼|TMUS181.79+4.27 (+2.41%) ▲|TSLA419.77+26.32 (+6.69%) ▲|TXN303.50+10.42 (+3.56%) ▲|UBER72.42-2.01 (-2.70%) ▼|UNH417.99-7.37 (-1.73%) ▼|UNP282.59+0.34 (+0.12%) ▲|UPS110.02-0.64 (-0.58%) ▼|USB62.83+1.10 (+1.78%) ▲|V357.25-4.88 (-1.35%) ▼|VZ42.07-0.49 (-1.15%) ▼|WFC87.45+1.94 (+2.27%) ▲|WMT110.65-1.19 (-1.06%) ▼|XOM136.44-0.65 (-0.47%) ▼|AAPL312.66+4.03 (+1.31%) ▲|ABBV254.76-6.31 (-2.42%) ▼|ABT95.63+0.23 (+0.24%) ▲|ACN136.96-0.39 (-0.28%) ▼|ADBE218.07-1.65 (-0.75%) ▼|AMAT592.79-10.25 (-1.70%) ▼|AMD552.05+34.23 (+6.61%) ▲|AMGN366.44-7.71 (-2.06%) ▼|AMT162.11-3.92 (-2.36%) ▼|AMZN244.16+1.49 (+0.61%) ▲|AVGO373.90+13.45 (+3.73%) ▲|AXP356.03+4.07 (+1.16%) ▲|BA234.54+8.05 (+3.55%) ▲|BAC59.90+1.17 (+1.99%) ▲|BKNG181.03-3.53 (-1.91%) ▼|BLK1,011.21+15.48 (+1.55%) ▲|BMY56.70-1.43 (-2.46%) ▼|BNY149.96+3.34 (+2.28%) ▲|BRK-B506.58-1.20 (-0.24%) ▼|C143.86+3.89 (+2.78%) ▲|CAT969.92+6.39 (+0.66%) ▲|CL93.39-1.74 (-1.83%) ▼|CMCSA23.38-0.41 (-1.72%) ▼|COF206.50+1.38 (+0.67%) ▲|COP103.58-1.15 (-1.10%) ▼|COST950.25-1.42 (-0.15%) ▼|CRM165.65-0.46 (-0.28%) ▼|CSCO113.98+1.29 (+1.14%) ▲|CVS102.08-2.64 (-2.52%) ▼|CVX168.10-1.10 (-0.65%) ▼|DE635.24+13.97 (+2.25%) ▲|DHR193.62-4.31 (-2.18%) ▼|DIS97.41-2.09 (-2.10%) ▼|DUK125.97-3.63 (-2.80%) ▼|EMR141.56+2.51 (+1.81%) ▲|FDX309.93-3.07 (-0.98%) ▼|GD376.88+3.34 (+0.89%) ▲|GE378.68+1.63 (+0.43%) ▲|GEV1,152.04+38.93 (+3.50%) ▲|GILD129.61-1.66 (-1.26%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG364.90+8.72 (+2.45%) ▲|GOOGL366.46+6.55 (+1.82%) ▲|GS1,055.29+34.29 (+3.36%) ▲|HD350.65-7.25 (-2.03%) ▼|HON231.18+1.32 (+0.57%) ▲|IBM299.52+10.00 (+3.45%) ▲|INTC122.20+1.85 (+1.54%) ▲|INTU272.14-3.21 (-1.17%) ▼|ISRG432.83+6.82 (+1.60%) ▲|JNJ259.33-3.71 (-1.41%) ▼|JPM337.72+4.75 (+1.43%) ▲|KO82.96-1.18 (-1.40%) ▼|LIN540.52-6.12 (-1.12%) ▼|LLY1,200.06-13.85 (-1.14%) ▼|LMT538.00-7.91 (-1.45%) ▼|LOW223.78-3.72 (-1.64%) ▼|LRCX350.20-1.21 (-0.34%) ▼|MA533.10-6.29 (-1.17%) ▼|MCD279.50-1.13 (-0.40%) ▼|MDLZ59.17-1.74 (-2.86%) ▼|MDT83.06-0.13 (-0.16%) ▼|META600.29+17.39 (+2.98%) ▲|MMM159.15-1.29 (-0.80%) ▼|MO71.88-0.83 (-1.14%) ▼|MRK126.78-2.78 (-2.15%) ▼|MS222.10+8.17 (+3.82%) ▲|MSFT386.74-3.75 (-0.96%) ▼|MU984.75+9.19 (+0.94%) ▲|NEE87.44-0.90 (-1.02%) ▼|NFLX76.02-1.63 (-2.10%) ▼|NKE43.34-0.75 (-1.70%) ▼|NOW107.93+1.61 (+1.51%) ▲|NVDA195.55+0.72 (+0.37%) ▲|ORCL143.76+3.49 (+2.49%) ▲|PEP143.29-0.93 (-0.64%) ▼|PFE23.72-0.60 (-2.47%) ▼|PG149.31-2.10 (-1.39%) ▼|PLTR132.54+3.24 (+2.51%) ▲|PM184.76+2.49 (+1.37%) ▲|QCOM186.48+10.23 (+5.80%) ▲|RTX201.37+2.12 (+1.06%) ▲|SBUX102.11-2.16 (-2.07%) ▼|SCHW100.62+3.62 (+3.73%) ▲|SO95.99-1.99 (-2.03%) ▼|SPG225.00-1.06 (-0.47%) ▼|T20.58+0.00 (+0.00%) ▲|TMO517.60-5.84 (-1.12%) ▼|TMUS181.79+4.27 (+2.41%) ▲|TSLA419.77+26.32 (+6.69%) ▲|TXN303.50+10.42 (+3.56%) ▲|UBER72.42-2.01 (-2.70%) ▼|UNH417.99-7.37 (-1.73%) ▼|UNP282.59+0.34 (+0.12%) ▲|UPS110.02-0.64 (-0.58%) ▼|USB62.83+1.10 (+1.78%) ▲|V357.25-4.88 (-1.35%) ▼|VZ42.07-0.49 (-1.15%) ▼|WFC87.45+1.94 (+2.27%) ▲|WMT110.65-1.19 (-1.06%) ▼|XOM136.44-0.65 (-0.47%) ▼|
17.9 C
New York
Tuesday, July 7, 2026

Tag: risk

EarthDaily Ignites a New Era in Earth Observation with Landmark Satellite Launch

Successful Launch of First Satellite Marks Critical Milestone in Deployment of Next Generation Earth Observation and Broad Area Change Detection System VANCOUVER, BC, June 25,...

Centrus Achieves Key Production Milestone with Delivery of 900 Kilograms of HALEU to the Department of Energy

BETHESDA, Md., June 25, 2025 /PRNewswire/ -- Centrus Energy (NYSE American: LEU) today announced that its wholly owned subsidiary, the American Centrifuge Operating, LLC,...

Zapp EV Reports Financial Results for the Six Months Ended March 31, 2025 and Provides Operational Update

Zapp EV Reports Financial Results for the Six Months Ended March 31, 2025 and Provides Operational Update

SmartVascular Dx™ Test: Enhancing Vascular Care in the Midwest

MorningStar Laboratories is now officially included in the Medicare fee schedule, enabling us to offer national medical coverage.

QFIIs Gain Access to Onshore ETF Options As A-share Market Opening Deepens

GUANGZHOU, China, June 25, 2025 /PRNewswire/ -- Qualified Foreign Institutional Investors (QFIIs) will be permitted to trade onshore ETF options starting October 9, exclusively...

Strategic Annuity Acquisition: Four Key Steps for Financial Executives

Establishing a reliable income stream through an immediate annuity requires a methodical approach to ensure financial security and longevity of returns. By adhering to...

3iQ Recognized as “Best Digital Asset Investment Manager”, “Best Bitcoin ETF Issuer” and “Fund Manager Innovator of the Year” at 2025 Industry Awards

TORONTO, June 25, 2025 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer in digital asset investment solutions, is pleased to announce it has won...

Zydus Wellness’ Glucon-D’s ‘Energy Ka Gola’ energizes thousands of children across India

~Distributed more than 700 kgs of Glucon-D infused Golas at 100+ stadiums and playgrounds, in Hyderabad, Kolkata, Lucknow, and Mumbai~~Launches film to help combat...

Telix Manufacturing Solutions Belgium Delivers First GMP-Grade Commercial Doses

MELBOURNE, Australia and INDIANAPOLIS, June 25, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its Telix Manufacturing...

Pan Finance Magazine Announces the Q2 Release and Award Winners of 2025

Pan Finance Magazine’s Q2 2025 edition highlights global market shifts, AI-driven sustainability trends, and announces its prestigious award winners.

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)

REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced positive topline results from a confirmatory efficacy study comparing AVT23 (ADL-018), a proposed biosimilar to Xolair® (omalizumab), with the reference biologic.

Nipocalimab showed greater sustained disease control versus approved FcRn blockers for generalised myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published...

The ITC compared all published Phase 3 data of these treatments, leveraging longitudinal results, and findings reinforce the importance of consistent, sustained disease control in managing a chronic autoantibody disease like gMG

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

−  Results show delivery of high radiation doses to tumours compared with normal organs.−  Observed normal organ absorbed dosimetry results may allow administration of...

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

−  Results show delivery of high radiation doses to tumours compared with normal organs.−  Observed normal organ absorbed dosimetry results may allow administration of...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRisk